Review



hyperoxia exposure chamber  (BioSpherix)


Bioz Verified Symbol BioSpherix is a verified supplier
Bioz Manufacturer Symbol BioSpherix manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 96
      Buy from Supplier

    Structured Review

    BioSpherix hyperoxia exposure chamber
    <t>Hyperoxia</t> impairs alveolar macrophage-mediated efferocytosis, and Nrf2-deficiency worsens it in vivo. Nrf2 +/+ (WT) and Nrf2 −/− mice ( n = 3 per group) were exposed to room air or hyperoxia for 48 h, and a set of hyperoxia-exposed mice were allowed to recover at room air for 72 as outlined in schema. ( a ) BAL from these mice was obtained, and macrophages were incubated on cover glasses with apoptotic neutrophils for 1 h. Macrophages were washed to remove unbound/non-internalized apoptotic cells and stained with Diff Quick stain. Images were captured to quantify apoptotic neutrophil binding, and internalization (indicated by red arrows). ( b ) Representative images of macrophages with neutrophils for each experimental condition are shown. ( c ) The number of apoptotic neutrophils either bound or internalized by macrophages from ~5–9 fields were quantified and expressed as % efferocytosis. Versus room air of respective genotypes, † Nrf2 −/− versus WT counterparts, § hyperoxia vs. recovery; †† p < 0.01; ****/§§§§/†††† p < 0.0001. Purple, room air group; Red, hyperoxia group; Green, hyperoxia and recovery.
    Hyperoxia Exposure Chamber, supplied by BioSpherix, used in various techniques. Bioz Stars score: 96/100, based on 419 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hyperoxia exposure chamber/product/BioSpherix
    Average 96 stars, based on 419 article reviews
    hyperoxia exposure chamber - by Bioz Stars, 2026-05
    96/100 stars

    Images

    1) Product Images from "Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury"

    Article Title: Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury

    Journal: Antioxidants

    doi: 10.3390/antiox11020212

    Hyperoxia impairs alveolar macrophage-mediated efferocytosis, and Nrf2-deficiency worsens it in vivo. Nrf2 +/+ (WT) and Nrf2 −/− mice ( n = 3 per group) were exposed to room air or hyperoxia for 48 h, and a set of hyperoxia-exposed mice were allowed to recover at room air for 72 as outlined in schema. ( a ) BAL from these mice was obtained, and macrophages were incubated on cover glasses with apoptotic neutrophils for 1 h. Macrophages were washed to remove unbound/non-internalized apoptotic cells and stained with Diff Quick stain. Images were captured to quantify apoptotic neutrophil binding, and internalization (indicated by red arrows). ( b ) Representative images of macrophages with neutrophils for each experimental condition are shown. ( c ) The number of apoptotic neutrophils either bound or internalized by macrophages from ~5–9 fields were quantified and expressed as % efferocytosis. Versus room air of respective genotypes, † Nrf2 −/− versus WT counterparts, § hyperoxia vs. recovery; †† p < 0.01; ****/§§§§/†††† p < 0.0001. Purple, room air group; Red, hyperoxia group; Green, hyperoxia and recovery.
    Figure Legend Snippet: Hyperoxia impairs alveolar macrophage-mediated efferocytosis, and Nrf2-deficiency worsens it in vivo. Nrf2 +/+ (WT) and Nrf2 −/− mice ( n = 3 per group) were exposed to room air or hyperoxia for 48 h, and a set of hyperoxia-exposed mice were allowed to recover at room air for 72 as outlined in schema. ( a ) BAL from these mice was obtained, and macrophages were incubated on cover glasses with apoptotic neutrophils for 1 h. Macrophages were washed to remove unbound/non-internalized apoptotic cells and stained with Diff Quick stain. Images were captured to quantify apoptotic neutrophil binding, and internalization (indicated by red arrows). ( b ) Representative images of macrophages with neutrophils for each experimental condition are shown. ( c ) The number of apoptotic neutrophils either bound or internalized by macrophages from ~5–9 fields were quantified and expressed as % efferocytosis. Versus room air of respective genotypes, † Nrf2 −/− versus WT counterparts, § hyperoxia vs. recovery; †† p < 0.01; ****/§§§§/†††† p < 0.0001. Purple, room air group; Red, hyperoxia group; Green, hyperoxia and recovery.

    Techniques Used: In Vivo, Incubation, Staining, Diff-Quik, Binding Assay

    Nrf2 is required for optimal macrophage-mediated efferocytosis. BMDMФs from Nrf2 +/+ (WT) and Nrf2 −/− mice were cultured and exposed to hyperoxia for 24 h. ( a ) Macrophages (green) were then incubated with labeled apoptotic neutrophils (red) for 1 h, washed, and captured images. ( b ) Macrophages were incubated with green fluorescent beads. Representative images of macrophages with neutrophils or beads for each genotype and experimental condition are shown. Values represent from at least three independent samples. * Room air versus hyperoxia of respective genotypes, †, Nrf2 −/− versus WT counterparts. * p < 0.05; **/†† p < 0.01; **** p < 0.0001. Blue, room air group; Red, hyperoxia group.
    Figure Legend Snippet: Nrf2 is required for optimal macrophage-mediated efferocytosis. BMDMФs from Nrf2 +/+ (WT) and Nrf2 −/− mice were cultured and exposed to hyperoxia for 24 h. ( a ) Macrophages (green) were then incubated with labeled apoptotic neutrophils (red) for 1 h, washed, and captured images. ( b ) Macrophages were incubated with green fluorescent beads. Representative images of macrophages with neutrophils or beads for each genotype and experimental condition are shown. Values represent from at least three independent samples. * Room air versus hyperoxia of respective genotypes, †, Nrf2 −/− versus WT counterparts. * p < 0.05; **/†† p < 0.01; **** p < 0.0001. Blue, room air group; Red, hyperoxia group.

    Techniques Used: Cell Culture, Incubation, Labeling

    Nrf2-deficiency in neutrophils does not affect their engulfment by macrophages. Neutrophils from the bone marrow of wild-type (WT) and Nrf2 −/− mice were isolated, labelled, and subjected to apoptosis as detailed in methods. Apoptotic neutrophils (red) were incubated with WT BMDMФs and Nrf2 −/− BMDMФs for 1 h, and efferocytosis was quantified. ( a ) Representative images of macrophages with apoptotic neutrophils (red). The blue color represents DAPI. ( b ) quantification of efferocytosis. Values are from 3–4 fields of two independent samples. † p < 0.05; Nrf2 −/− versus WT counterparts. Blue, room air group; pink hyperoxia group.
    Figure Legend Snippet: Nrf2-deficiency in neutrophils does not affect their engulfment by macrophages. Neutrophils from the bone marrow of wild-type (WT) and Nrf2 −/− mice were isolated, labelled, and subjected to apoptosis as detailed in methods. Apoptotic neutrophils (red) were incubated with WT BMDMФs and Nrf2 −/− BMDMФs for 1 h, and efferocytosis was quantified. ( a ) Representative images of macrophages with apoptotic neutrophils (red). The blue color represents DAPI. ( b ) quantification of efferocytosis. Values are from 3–4 fields of two independent samples. † p < 0.05; Nrf2 −/− versus WT counterparts. Blue, room air group; pink hyperoxia group.

    Techniques Used: Isolation, Incubation

    Nrf2 regulates apoptotic neutrophil binding to the macrophages. Nrf2 +/+ (WT) and Nrf2 −/− BMDMФs were exposed to room air or hyperoxia and then incubated with cytochalasin D (CtyD) before adding the labeled apoptotic neutrophils. Efferocytosis was quantified. ( a ) Both bound/attached and internalized apoptotic cells in the presence and absence of CytD were enumerated, and data are represented % efferocytosis. * hyperoxia versus room air of respective genotypes, †, Nrf2 −/− versus WT counterparts; § DMSO versus CtyD of respective genotypes. */† p < 0.05; **/§§ p < 0.01; ***/†††/§§§ p < 0.001; §§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group. ( b ) Both bound and internalized apoptotic cells were enumerated by comparing values of respective CytD (bound) and DMSO-treated (bound and internalized) samples, * Hyperoxia versus room air of respective genotypes, and §, Nrf2 −/− versus WT versus counterparts. Values are from three independent samples. * p < 0.05; **/§§ p < 0.01; §§§ p < 0.001. Blue, room air group; Red, hyperoxia group.
    Figure Legend Snippet: Nrf2 regulates apoptotic neutrophil binding to the macrophages. Nrf2 +/+ (WT) and Nrf2 −/− BMDMФs were exposed to room air or hyperoxia and then incubated with cytochalasin D (CtyD) before adding the labeled apoptotic neutrophils. Efferocytosis was quantified. ( a ) Both bound/attached and internalized apoptotic cells in the presence and absence of CytD were enumerated, and data are represented % efferocytosis. * hyperoxia versus room air of respective genotypes, †, Nrf2 −/− versus WT counterparts; § DMSO versus CtyD of respective genotypes. */† p < 0.05; **/§§ p < 0.01; ***/†††/§§§ p < 0.001; §§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group. ( b ) Both bound and internalized apoptotic cells were enumerated by comparing values of respective CytD (bound) and DMSO-treated (bound and internalized) samples, * Hyperoxia versus room air of respective genotypes, and §, Nrf2 −/− versus WT versus counterparts. Values are from three independent samples. * p < 0.05; **/§§ p < 0.01; §§§ p < 0.001. Blue, room air group; Red, hyperoxia group.

    Techniques Used: Binding Assay, Incubation, Labeling

    Nrf2 activation augments efferocytosis in hyperoxia exposed BMDMΦs. Nrf2 +/+ and Nrf2 −/− BMDMΦs were pretreated with CDDO-Im (20 nM) for 6 h and exposed to hyperoxia for 24 h along with CDDO-Im. After hyperoxia, BMDMΦs were incubated with CellTracker Red stained apoptotic neutrophils for 1 hour. Images were captured, and % efferocytosis was enumerated. Values are at least from three independent samples. * Hyperoxia versus room air of respective genotypes, † versus WT counterparts, and § DMSO versus CDDO of respective genotypes. § p < 0.05; ****/††††/§§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group.
    Figure Legend Snippet: Nrf2 activation augments efferocytosis in hyperoxia exposed BMDMΦs. Nrf2 +/+ and Nrf2 −/− BMDMΦs were pretreated with CDDO-Im (20 nM) for 6 h and exposed to hyperoxia for 24 h along with CDDO-Im. After hyperoxia, BMDMΦs were incubated with CellTracker Red stained apoptotic neutrophils for 1 hour. Images were captured, and % efferocytosis was enumerated. Values are at least from three independent samples. * Hyperoxia versus room air of respective genotypes, † versus WT counterparts, and § DMSO versus CDDO of respective genotypes. § p < 0.05; ****/††††/§§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group.

    Techniques Used: Activation Assay, Incubation, Staining



    Similar Products

    hyperoxia exposure chamber  (BioSpherix)
    96
    BioSpherix hyperoxia exposure chamber
    <t>Hyperoxia</t> impairs alveolar macrophage-mediated efferocytosis, and Nrf2-deficiency worsens it in vivo. Nrf2 +/+ (WT) and Nrf2 −/− mice ( n = 3 per group) were exposed to room air or hyperoxia for 48 h, and a set of hyperoxia-exposed mice were allowed to recover at room air for 72 as outlined in schema. ( a ) BAL from these mice was obtained, and macrophages were incubated on cover glasses with apoptotic neutrophils for 1 h. Macrophages were washed to remove unbound/non-internalized apoptotic cells and stained with Diff Quick stain. Images were captured to quantify apoptotic neutrophil binding, and internalization (indicated by red arrows). ( b ) Representative images of macrophages with neutrophils for each experimental condition are shown. ( c ) The number of apoptotic neutrophils either bound or internalized by macrophages from ~5–9 fields were quantified and expressed as % efferocytosis. Versus room air of respective genotypes, † Nrf2 −/− versus WT counterparts, § hyperoxia vs. recovery; †† p < 0.01; ****/§§§§/†††† p < 0.0001. Purple, room air group; Red, hyperoxia group; Green, hyperoxia and recovery.
    Hyperoxia Exposure Chamber, supplied by BioSpherix, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/hyperoxia exposure chamber/product/BioSpherix
    Average 96 stars, based on 1 article reviews
    hyperoxia exposure chamber - by Bioz Stars, 2026-05
    96/100 stars
    		  Buy from Supplier
    incubator chamber hyperoxia exposure  (Billups-Rothenberg inc)
    90
    Billups-Rothenberg inc incubator chamber hyperoxia exposure
    Role of nmMLCK in <t>hyperoxia-mediated</t> ROS and superoxide production in HPAECs. HPAECs grown on 35-mm dishes (∼90% confluence) were pretreated with increasing concentrations of ML-7 for 30 min and exposed to normoxia or hyperoxia for 3 h, and total ROS and superoxide accumulations were measured by DCFDA and hydroethidine immunofluorescence (A and B). In C, E, F, and G, HPAECs were transfected with scrambled (scRNA) or nmMLCK siRNA (50 nm) for 72 h as described under “Experimental Procedures.” Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different from normoxia (p < 0.05); **, significantly different from untreated hyperoxia (p < 0.01). Total RNA was isolated from scrambled and nmMLCK siRNA-transfected cells, and real-time PCR was performed in a Light Cycler using SYBR Green QuantiTect (C). Data are from three independent experiments and are expressed as relative gene expression normalized to 18 S RNA. In D and E, cell lysates (20 μg of proteins) from ML-7, scrambled or nmMLCK siRNA-transfected cells were subjected to SDS-PAGE on 10% precast Tris-glycine gels and Western-blotted (IB) with anti-nmMLCK, phospho-MLC, and MLC antibodies. Shown is a representative blot of three independent experiments. In F and G, HPAECs were transfected with scrambled RNA or nmMLCK siRNA (50 nm) for 72 h, and cells were loaded with 10 μm DCFDA (F) or hydroethidine (G) for 30 min before exposure to normoxia or hyperoxia for 3 h. Formation of total ROS (F) and superoxide (G) was quantified as described above. Values are the mean ± S.D. of three independent experiments in triplicate. *, significantly different from normoxia (N) (p < 0.05); **, significantly different from hyperoxia exposure (HO) (p < 0.01).
    Incubator Chamber Hyperoxia Exposure, supplied by Billups-Rothenberg inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/incubator chamber hyperoxia exposure/product/Billups-Rothenberg inc
    Average 90 stars, based on 1 article reviews
    incubator chamber hyperoxia exposure - by Bioz Stars, 2026-05
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Hyperoxia impairs alveolar macrophage-mediated efferocytosis, and Nrf2-deficiency worsens it in vivo. Nrf2 +/+ (WT) and Nrf2 −/− mice ( n = 3 per group) were exposed to room air or hyperoxia for 48 h, and a set of hyperoxia-exposed mice were allowed to recover at room air for 72 as outlined in schema. ( a ) BAL from these mice was obtained, and macrophages were incubated on cover glasses with apoptotic neutrophils for 1 h. Macrophages were washed to remove unbound/non-internalized apoptotic cells and stained with Diff Quick stain. Images were captured to quantify apoptotic neutrophil binding, and internalization (indicated by red arrows). ( b ) Representative images of macrophages with neutrophils for each experimental condition are shown. ( c ) The number of apoptotic neutrophils either bound or internalized by macrophages from ~5–9 fields were quantified and expressed as % efferocytosis. Versus room air of respective genotypes, † Nrf2 −/− versus WT counterparts, § hyperoxia vs. recovery; †† p < 0.01; ****/§§§§/†††† p < 0.0001. Purple, room air group; Red, hyperoxia group; Green, hyperoxia and recovery.

    Journal: Antioxidants

    Article Title: Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury

    doi: 10.3390/antiox11020212

    Figure Lengend Snippet: Hyperoxia impairs alveolar macrophage-mediated efferocytosis, and Nrf2-deficiency worsens it in vivo. Nrf2 +/+ (WT) and Nrf2 −/− mice ( n = 3 per group) were exposed to room air or hyperoxia for 48 h, and a set of hyperoxia-exposed mice were allowed to recover at room air for 72 as outlined in schema. ( a ) BAL from these mice was obtained, and macrophages were incubated on cover glasses with apoptotic neutrophils for 1 h. Macrophages were washed to remove unbound/non-internalized apoptotic cells and stained with Diff Quick stain. Images were captured to quantify apoptotic neutrophil binding, and internalization (indicated by red arrows). ( b ) Representative images of macrophages with neutrophils for each experimental condition are shown. ( c ) The number of apoptotic neutrophils either bound or internalized by macrophages from ~5–9 fields were quantified and expressed as % efferocytosis. Versus room air of respective genotypes, † Nrf2 −/− versus WT counterparts, § hyperoxia vs. recovery; †† p < 0.01; ****/§§§§/†††† p < 0.0001. Purple, room air group; Red, hyperoxia group; Green, hyperoxia and recovery.

    Article Snippet: Mice cages were placed in a hyperoxia exposure chamber (Cat # A30274, BioSpherix, Ltd., Parish, NY, USA).

    Techniques: In Vivo, Incubation, Staining, Diff-Quik, Binding Assay

    Nrf2 is required for optimal macrophage-mediated efferocytosis. BMDMФs from Nrf2 +/+ (WT) and Nrf2 −/− mice were cultured and exposed to hyperoxia for 24 h. ( a ) Macrophages (green) were then incubated with labeled apoptotic neutrophils (red) for 1 h, washed, and captured images. ( b ) Macrophages were incubated with green fluorescent beads. Representative images of macrophages with neutrophils or beads for each genotype and experimental condition are shown. Values represent from at least three independent samples. * Room air versus hyperoxia of respective genotypes, †, Nrf2 −/− versus WT counterparts. * p < 0.05; **/†† p < 0.01; **** p < 0.0001. Blue, room air group; Red, hyperoxia group.

    Journal: Antioxidants

    Article Title: Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury

    doi: 10.3390/antiox11020212

    Figure Lengend Snippet: Nrf2 is required for optimal macrophage-mediated efferocytosis. BMDMФs from Nrf2 +/+ (WT) and Nrf2 −/− mice were cultured and exposed to hyperoxia for 24 h. ( a ) Macrophages (green) were then incubated with labeled apoptotic neutrophils (red) for 1 h, washed, and captured images. ( b ) Macrophages were incubated with green fluorescent beads. Representative images of macrophages with neutrophils or beads for each genotype and experimental condition are shown. Values represent from at least three independent samples. * Room air versus hyperoxia of respective genotypes, †, Nrf2 −/− versus WT counterparts. * p < 0.05; **/†† p < 0.01; **** p < 0.0001. Blue, room air group; Red, hyperoxia group.

    Article Snippet: Mice cages were placed in a hyperoxia exposure chamber (Cat # A30274, BioSpherix, Ltd., Parish, NY, USA).

    Techniques: Cell Culture, Incubation, Labeling

    Nrf2-deficiency in neutrophils does not affect their engulfment by macrophages. Neutrophils from the bone marrow of wild-type (WT) and Nrf2 −/− mice were isolated, labelled, and subjected to apoptosis as detailed in methods. Apoptotic neutrophils (red) were incubated with WT BMDMФs and Nrf2 −/− BMDMФs for 1 h, and efferocytosis was quantified. ( a ) Representative images of macrophages with apoptotic neutrophils (red). The blue color represents DAPI. ( b ) quantification of efferocytosis. Values are from 3–4 fields of two independent samples. † p < 0.05; Nrf2 −/− versus WT counterparts. Blue, room air group; pink hyperoxia group.

    Journal: Antioxidants

    Article Title: Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury

    doi: 10.3390/antiox11020212

    Figure Lengend Snippet: Nrf2-deficiency in neutrophils does not affect their engulfment by macrophages. Neutrophils from the bone marrow of wild-type (WT) and Nrf2 −/− mice were isolated, labelled, and subjected to apoptosis as detailed in methods. Apoptotic neutrophils (red) were incubated with WT BMDMФs and Nrf2 −/− BMDMФs for 1 h, and efferocytosis was quantified. ( a ) Representative images of macrophages with apoptotic neutrophils (red). The blue color represents DAPI. ( b ) quantification of efferocytosis. Values are from 3–4 fields of two independent samples. † p < 0.05; Nrf2 −/− versus WT counterparts. Blue, room air group; pink hyperoxia group.

    Article Snippet: Mice cages were placed in a hyperoxia exposure chamber (Cat # A30274, BioSpherix, Ltd., Parish, NY, USA).

    Techniques: Isolation, Incubation

    Nrf2 regulates apoptotic neutrophil binding to the macrophages. Nrf2 +/+ (WT) and Nrf2 −/− BMDMФs were exposed to room air or hyperoxia and then incubated with cytochalasin D (CtyD) before adding the labeled apoptotic neutrophils. Efferocytosis was quantified. ( a ) Both bound/attached and internalized apoptotic cells in the presence and absence of CytD were enumerated, and data are represented % efferocytosis. * hyperoxia versus room air of respective genotypes, †, Nrf2 −/− versus WT counterparts; § DMSO versus CtyD of respective genotypes. */† p < 0.05; **/§§ p < 0.01; ***/†††/§§§ p < 0.001; §§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group. ( b ) Both bound and internalized apoptotic cells were enumerated by comparing values of respective CytD (bound) and DMSO-treated (bound and internalized) samples, * Hyperoxia versus room air of respective genotypes, and §, Nrf2 −/− versus WT versus counterparts. Values are from three independent samples. * p < 0.05; **/§§ p < 0.01; §§§ p < 0.001. Blue, room air group; Red, hyperoxia group.

    Journal: Antioxidants

    Article Title: Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury

    doi: 10.3390/antiox11020212

    Figure Lengend Snippet: Nrf2 regulates apoptotic neutrophil binding to the macrophages. Nrf2 +/+ (WT) and Nrf2 −/− BMDMФs were exposed to room air or hyperoxia and then incubated with cytochalasin D (CtyD) before adding the labeled apoptotic neutrophils. Efferocytosis was quantified. ( a ) Both bound/attached and internalized apoptotic cells in the presence and absence of CytD were enumerated, and data are represented % efferocytosis. * hyperoxia versus room air of respective genotypes, †, Nrf2 −/− versus WT counterparts; § DMSO versus CtyD of respective genotypes. */† p < 0.05; **/§§ p < 0.01; ***/†††/§§§ p < 0.001; §§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group. ( b ) Both bound and internalized apoptotic cells were enumerated by comparing values of respective CytD (bound) and DMSO-treated (bound and internalized) samples, * Hyperoxia versus room air of respective genotypes, and §, Nrf2 −/− versus WT versus counterparts. Values are from three independent samples. * p < 0.05; **/§§ p < 0.01; §§§ p < 0.001. Blue, room air group; Red, hyperoxia group.

    Article Snippet: Mice cages were placed in a hyperoxia exposure chamber (Cat # A30274, BioSpherix, Ltd., Parish, NY, USA).

    Techniques: Binding Assay, Incubation, Labeling

    Nrf2 activation augments efferocytosis in hyperoxia exposed BMDMΦs. Nrf2 +/+ and Nrf2 −/− BMDMΦs were pretreated with CDDO-Im (20 nM) for 6 h and exposed to hyperoxia for 24 h along with CDDO-Im. After hyperoxia, BMDMΦs were incubated with CellTracker Red stained apoptotic neutrophils for 1 hour. Images were captured, and % efferocytosis was enumerated. Values are at least from three independent samples. * Hyperoxia versus room air of respective genotypes, † versus WT counterparts, and § DMSO versus CDDO of respective genotypes. § p < 0.05; ****/††††/§§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group.

    Journal: Antioxidants

    Article Title: Nrf2 Is Required for Optimal Alveolar-Macrophage-Mediated Apoptotic Neutrophil Clearance after Oxidant Injury

    doi: 10.3390/antiox11020212

    Figure Lengend Snippet: Nrf2 activation augments efferocytosis in hyperoxia exposed BMDMΦs. Nrf2 +/+ and Nrf2 −/− BMDMΦs were pretreated with CDDO-Im (20 nM) for 6 h and exposed to hyperoxia for 24 h along with CDDO-Im. After hyperoxia, BMDMΦs were incubated with CellTracker Red stained apoptotic neutrophils for 1 hour. Images were captured, and % efferocytosis was enumerated. Values are at least from three independent samples. * Hyperoxia versus room air of respective genotypes, † versus WT counterparts, and § DMSO versus CDDO of respective genotypes. § p < 0.05; ****/††††/§§§§ p < 0.0001. Blue, room air group; Red, hyperoxia group.

    Article Snippet: Mice cages were placed in a hyperoxia exposure chamber (Cat # A30274, BioSpherix, Ltd., Parish, NY, USA).

    Techniques: Activation Assay, Incubation, Staining

    Role of nmMLCK in hyperoxia-mediated ROS and superoxide production in HPAECs. HPAECs grown on 35-mm dishes (∼90% confluence) were pretreated with increasing concentrations of ML-7 for 30 min and exposed to normoxia or hyperoxia for 3 h, and total ROS and superoxide accumulations were measured by DCFDA and hydroethidine immunofluorescence (A and B). In C, E, F, and G, HPAECs were transfected with scrambled (scRNA) or nmMLCK siRNA (50 nm) for 72 h as described under “Experimental Procedures.” Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different from normoxia (p < 0.05); **, significantly different from untreated hyperoxia (p < 0.01). Total RNA was isolated from scrambled and nmMLCK siRNA-transfected cells, and real-time PCR was performed in a Light Cycler using SYBR Green QuantiTect (C). Data are from three independent experiments and are expressed as relative gene expression normalized to 18 S RNA. In D and E, cell lysates (20 μg of proteins) from ML-7, scrambled or nmMLCK siRNA-transfected cells were subjected to SDS-PAGE on 10% precast Tris-glycine gels and Western-blotted (IB) with anti-nmMLCK, phospho-MLC, and MLC antibodies. Shown is a representative blot of three independent experiments. In F and G, HPAECs were transfected with scrambled RNA or nmMLCK siRNA (50 nm) for 72 h, and cells were loaded with 10 μm DCFDA (F) or hydroethidine (G) for 30 min before exposure to normoxia or hyperoxia for 3 h. Formation of total ROS (F) and superoxide (G) was quantified as described above. Values are the mean ± S.D. of three independent experiments in triplicate. *, significantly different from normoxia (N) (p < 0.05); **, significantly different from hyperoxia exposure (HO) (p < 0.01).

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Role of nmMLCK in hyperoxia-mediated ROS and superoxide production in HPAECs. HPAECs grown on 35-mm dishes (∼90% confluence) were pretreated with increasing concentrations of ML-7 for 30 min and exposed to normoxia or hyperoxia for 3 h, and total ROS and superoxide accumulations were measured by DCFDA and hydroethidine immunofluorescence (A and B). In C, E, F, and G, HPAECs were transfected with scrambled (scRNA) or nmMLCK siRNA (50 nm) for 72 h as described under “Experimental Procedures.” Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different from normoxia (p < 0.05); **, significantly different from untreated hyperoxia (p < 0.01). Total RNA was isolated from scrambled and nmMLCK siRNA-transfected cells, and real-time PCR was performed in a Light Cycler using SYBR Green QuantiTect (C). Data are from three independent experiments and are expressed as relative gene expression normalized to 18 S RNA. In D and E, cell lysates (20 μg of proteins) from ML-7, scrambled or nmMLCK siRNA-transfected cells were subjected to SDS-PAGE on 10% precast Tris-glycine gels and Western-blotted (IB) with anti-nmMLCK, phospho-MLC, and MLC antibodies. Shown is a representative blot of three independent experiments. In F and G, HPAECs were transfected with scrambled RNA or nmMLCK siRNA (50 nm) for 72 h, and cells were loaded with 10 μm DCFDA (F) or hydroethidine (G) for 30 min before exposure to normoxia or hyperoxia for 3 h. Formation of total ROS (F) and superoxide (G) was quantified as described above. Values are the mean ± S.D. of three independent experiments in triplicate. *, significantly different from normoxia (N) (p < 0.05); **, significantly different from hyperoxia exposure (HO) (p < 0.01).

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Immunofluorescence, Transfection, Isolation, Real-time Polymerase Chain Reaction, SYBR Green Assay, Expressing, SDS Page, Western Blot

    Overexpression of nmMLCK potentiates hyperoxia-induced ROS and superoxide production in HPAECs. HPAECs grown on 35-mm dishes (∼60% confluence) were transfected with vector control or FLAG-tagged nmMLCK WT (1 μg/ml) using FuGENE HD (3 μg/ml) transfection reagent for 72 h as described under “Experimental Procedures.” A, cell lysates (20 μg of proteins) from vector control and FLAG-tagged nmMLCK transfected cells were subjected to SDS-PAGE and immunoblotted with anti-MLCK, anti-FLAG and anti-actin antibodies. A representative immunoblot from three independent experiments is shown. B and C, vector control and FLAG-tagged nmMLCK (WT)-transfected cells were loaded with 10 μm DCFDA (B) or hydroethidine (C) for 30 min before exposure to normoxia (N) or HO for 3 h. Formation of total ROS (B) and superoxide (C) were quantified as described under “Experimental Procedures.” Values are the mean ± S.D. of three independent experiments in triplicate. *, significantly different from normoxia (N) (p < 0.05); **, significantly different from vector control cells exposed to hyperoxia (HO) (p < 0.001).

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Overexpression of nmMLCK potentiates hyperoxia-induced ROS and superoxide production in HPAECs. HPAECs grown on 35-mm dishes (∼60% confluence) were transfected with vector control or FLAG-tagged nmMLCK WT (1 μg/ml) using FuGENE HD (3 μg/ml) transfection reagent for 72 h as described under “Experimental Procedures.” A, cell lysates (20 μg of proteins) from vector control and FLAG-tagged nmMLCK transfected cells were subjected to SDS-PAGE and immunoblotted with anti-MLCK, anti-FLAG and anti-actin antibodies. A representative immunoblot from three independent experiments is shown. B and C, vector control and FLAG-tagged nmMLCK (WT)-transfected cells were loaded with 10 μm DCFDA (B) or hydroethidine (C) for 30 min before exposure to normoxia (N) or HO for 3 h. Formation of total ROS (B) and superoxide (C) were quantified as described under “Experimental Procedures.” Values are the mean ± S.D. of three independent experiments in triplicate. *, significantly different from normoxia (N) (p < 0.05); **, significantly different from vector control cells exposed to hyperoxia (HO) (p < 0.001).

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Over Expression, Transfection, Plasmid Preparation, SDS Page, Western Blot

    nmMLCK siRNA attenuates hyperoxia-induced phosphorylation of MLC and cortactin and actin rearrangement in HPAECs. HPAECs grown on 8-well slide chambers were transfected with scrambled RNA or nmMLCK siRNA (50 nm) for 72 h before exposure to either normoxia (N) or HO for 3 h, washed, fixed, permeabilized, and probed with anti-phospho-cortactin, anti-phospho-MLC antibodies, or phalloidin for actin staining. nmMLCK siRNA blunted hyperoxia-induced phosphorylation of cortactin and MLC near the cell periphery and enhanced actin stress fibers under both normoxia and hyperoxia as determined by immunofluorescent microscopy. A representative immunofluorescence image from three independent experiments is shown.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: nmMLCK siRNA attenuates hyperoxia-induced phosphorylation of MLC and cortactin and actin rearrangement in HPAECs. HPAECs grown on 8-well slide chambers were transfected with scrambled RNA or nmMLCK siRNA (50 nm) for 72 h before exposure to either normoxia (N) or HO for 3 h, washed, fixed, permeabilized, and probed with anti-phospho-cortactin, anti-phospho-MLC antibodies, or phalloidin for actin staining. nmMLCK siRNA blunted hyperoxia-induced phosphorylation of cortactin and MLC near the cell periphery and enhanced actin stress fibers under both normoxia and hyperoxia as determined by immunofluorescent microscopy. A representative immunofluorescence image from three independent experiments is shown.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Transfection, Staining, Microscopy, Immunofluorescence

    Down-regulation of nmMLCK with nmMLCK siRNA blunted hyperoxia-induced translocation and co-localization of p47phox with cortactin. HPAECs grown on 8-well slide chambers were transfected with scrambled siRNA or MLCK siRNA for 72 h then exposed to normoxia or hyperoxia (3 h), washed, fixed, permeabilized, probed with anti-cortactin or anti-p47phox antibodies, and examined by immunofluorescence microscopy using a 60× oil objective. The cortactin (red) and p47phox (green) images show matched cell fields for each condition. Exposure of cells to hyperoxia resulted in redistribution of cortactin and p47phox to the cell periphery, whereas MLCK siRNA blunted cortactin and p47phox redistribution and co-localization (yellow in merged images). A representative image from three independent experiments is shown.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Down-regulation of nmMLCK with nmMLCK siRNA blunted hyperoxia-induced translocation and co-localization of p47phox with cortactin. HPAECs grown on 8-well slide chambers were transfected with scrambled siRNA or MLCK siRNA for 72 h then exposed to normoxia or hyperoxia (3 h), washed, fixed, permeabilized, probed with anti-cortactin or anti-p47phox antibodies, and examined by immunofluorescence microscopy using a 60× oil objective. The cortactin (red) and p47phox (green) images show matched cell fields for each condition. Exposure of cells to hyperoxia resulted in redistribution of cortactin and p47phox to the cell periphery, whereas MLCK siRNA blunted cortactin and p47phox redistribution and co-localization (yellow in merged images). A representative image from three independent experiments is shown.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Translocation Assay, Transfection, Immunofluorescence, Microscopy

    Overexpression of MLCK-FLAG wild type enhances hyperoxia-induced association of nmMLCK with cortactin and p47phox in cell periphery. HPAECs grown on 8-well slide chambers were transfected with vector control or FLAG-tagged MLCK wild type (1 μg/ml) and FuGENE HD (3 μg/ml) transfection reagent for 72 h and then exposed to either normoxia (N) or HO for 3 h. Cells were, washed, fixed, permeabilized, and probed with anti-cortactin (A), anti-p47phox (B), or anti-FLAG (A and B) antibodies and examined by immunofluorescence microscopy using a 60× oil objective. Exposure of cells to hyperoxia resulted in redistribution of cortactin and p47phox to the cell periphery with enhanced nmMLCK association and co-localization (yellow in merged images). Shown is a representative image from three independent experiments. C and D represent semiquantitation of the co-localization using an image analyzer showed an ∼2.0-fold increase in co-localization (yellow) between nmMLCK (red) and cortactin (green) and an ∼2.5-fold increase in co-localization between nmMLCK and p47phox.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Overexpression of MLCK-FLAG wild type enhances hyperoxia-induced association of nmMLCK with cortactin and p47phox in cell periphery. HPAECs grown on 8-well slide chambers were transfected with vector control or FLAG-tagged MLCK wild type (1 μg/ml) and FuGENE HD (3 μg/ml) transfection reagent for 72 h and then exposed to either normoxia (N) or HO for 3 h. Cells were, washed, fixed, permeabilized, and probed with anti-cortactin (A), anti-p47phox (B), or anti-FLAG (A and B) antibodies and examined by immunofluorescence microscopy using a 60× oil objective. Exposure of cells to hyperoxia resulted in redistribution of cortactin and p47phox to the cell periphery with enhanced nmMLCK association and co-localization (yellow in merged images). Shown is a representative image from three independent experiments. C and D represent semiquantitation of the co-localization using an image analyzer showed an ∼2.0-fold increase in co-localization (yellow) between nmMLCK (red) and cortactin (green) and an ∼2.5-fold increase in co-localization between nmMLCK and p47phox.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Over Expression, Transfection, Plasmid Preparation, Immunofluorescence, Microscopy

    Down-regulation of nmMLCK with nmMLCK siRNA blunted the hyperoxia-induced association of cortactin with Src and p47phox and phosphorylation of cortactin, Src, and p47phox in HPAECs. A, HPAECs grown in 100-mm dishes to ∼90% confluence were exposed to either normoxia (N) or HO for 3 h. Cell lysates (500 μg proteins) from normoxia- or HO-exposed cells were immunoprecipitated (IP) with anti-nmMLCK antibody as described under “Experimental Procedures.” Immunoprecipitates were analyzed by 10% SDS-PAGE and probed with anti-nmMLCK, anti-cortactin, anti-Src, anti-p47phox, anti-actin, and anti-MLC antibodies. A representative blot from three independent experiments is shown. IB, immunoblot. B, HPAECs grown in 100-mm dishes to ∼50% confluence were transfected with scrambled (sc) RNA or nmMLCK siRNA (50 nm) for 72 h, and down-regulation of nmMLCK expression was verified by Western blotting as described under “Experimental Procedures.” Total cell lysates (500 μg of proteins) from scrambled and nmMLCK siRNA-treated cells were subjected to immunoprecipitation with anti-cortactin antibody, and immunoprecipitates were analyzed by 10% SDS-PAGE and probed with anti-cortactin (equal loading), anti-Src, anti-p47phox, anti-phosphotyrosine and anti-MLC antibodies. A representative blot from three independent experiments is shown.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Down-regulation of nmMLCK with nmMLCK siRNA blunted the hyperoxia-induced association of cortactin with Src and p47phox and phosphorylation of cortactin, Src, and p47phox in HPAECs. A, HPAECs grown in 100-mm dishes to ∼90% confluence were exposed to either normoxia (N) or HO for 3 h. Cell lysates (500 μg proteins) from normoxia- or HO-exposed cells were immunoprecipitated (IP) with anti-nmMLCK antibody as described under “Experimental Procedures.” Immunoprecipitates were analyzed by 10% SDS-PAGE and probed with anti-nmMLCK, anti-cortactin, anti-Src, anti-p47phox, anti-actin, and anti-MLC antibodies. A representative blot from three independent experiments is shown. IB, immunoblot. B, HPAECs grown in 100-mm dishes to ∼50% confluence were transfected with scrambled (sc) RNA or nmMLCK siRNA (50 nm) for 72 h, and down-regulation of nmMLCK expression was verified by Western blotting as described under “Experimental Procedures.” Total cell lysates (500 μg of proteins) from scrambled and nmMLCK siRNA-treated cells were subjected to immunoprecipitation with anti-cortactin antibody, and immunoprecipitates were analyzed by 10% SDS-PAGE and probed with anti-cortactin (equal loading), anti-Src, anti-p47phox, anti-phosphotyrosine and anti-MLC antibodies. A representative blot from three independent experiments is shown.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Immunoprecipitation, SDS Page, Western Blot, Transfection, Expressing

    nmMLCK regulates hyperoxia-induced enrichment of cortactin, Src, and p47phox in caveolin-enriched microdomains. HPAECs grown in 100-mm dishes were transfected with scrambled (sc) RNA or nmMLCK siRNA (50 nm) for 72 h (A) or pretreated with ML-7 (1 μm, 30 min) (B) before exposure to either normoxia (N) or HO for 3 h, and caveolin-enriched microdomains were isolated as described under “Experimental Procedures.” Samples were then analyzed by 4–20% SDS-PAGE and probed with anti-cortactin, anti-Src, anti-p47phox, anti-MLC, anti-actin, anti-phospho-cortactin, anti-phospho-Src, and anti-phospho-MLC antibodies. Immunoblots (IB) were quantified by ImageJ software and expressed as a ratio to total caveolin-1. Values are the mean ± S.D. from three independent experiments. *, significantly different from normoxia (p < 0.05); **, significantly different from scrambled siRNA transfected cells exposed to hyperoxia.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: nmMLCK regulates hyperoxia-induced enrichment of cortactin, Src, and p47phox in caveolin-enriched microdomains. HPAECs grown in 100-mm dishes were transfected with scrambled (sc) RNA or nmMLCK siRNA (50 nm) for 72 h (A) or pretreated with ML-7 (1 μm, 30 min) (B) before exposure to either normoxia (N) or HO for 3 h, and caveolin-enriched microdomains were isolated as described under “Experimental Procedures.” Samples were then analyzed by 4–20% SDS-PAGE and probed with anti-cortactin, anti-Src, anti-p47phox, anti-MLC, anti-actin, anti-phospho-cortactin, anti-phospho-Src, and anti-phospho-MLC antibodies. Immunoblots (IB) were quantified by ImageJ software and expressed as a ratio to total caveolin-1. Values are the mean ± S.D. from three independent experiments. *, significantly different from normoxia (p < 0.05); **, significantly different from scrambled siRNA transfected cells exposed to hyperoxia.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Transfection, Isolation, SDS Page, Western Blot, Software

    nmMLCK-KO mice exhibit reduced lung injury, leakage, and inflammation and ROS production in vivo. Male C57BL/6 WT or nmMLCK knock out (−/−) mice in the same background were exposed to either normoxia (N) or HO for 72 h. At the end of the experiment mice were anesthetized, BAL fluid was collected, lungs were perfused with fresh PBS several times, and whole lungs without trachea were paraffin-embedded. A–C, paraffin-embedded lung tissues from normoxia or HO animals were, sectioned, and immunostained with anti-phospho-MLC (A), anti-phospho-Src (B), or anti-phospho-cortactin (C) antibodies and examined under immunofluorescence microscopy using 60× oil objective. D, lung tissues from normoxia or HO-exposed animals were stored in formalin for 24 h before processing for staining with hematoxylin and eosin and lung morphology was evaluated using 40 X objective. E, BAL fluid collected from normoxia- or HO-exposed animals were subjected to cytospin, and differential cell counts were performed. Shown is a graphic representation of macrophages (M) and neutrophils (N) in BAL fluid from wild type and nmMLCK−/− mice exposed to normoxia or hyperoxia. Values are the mean ± S.D. from three independent experiments. *, significantly different from animals exposed to normoxia (p < 0.05); **, significantly different from animals exposed to normoxia (p < 0.01); ***, significantly different from wild type mice exposed to hyperoxia (p < 0.005). F and G, BAL fluid from mice exposed to normoxia or hyperoxia was analyzed for H2O2 (F) and total protein (G). Values are the mean ± S.D. from three independent experiments. *, significantly different from animals exposed to normoxia (p < 0.05); **, significantly different from wild type animals exposed to hyperoxia (p < 0.01).

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: nmMLCK-KO mice exhibit reduced lung injury, leakage, and inflammation and ROS production in vivo. Male C57BL/6 WT or nmMLCK knock out (−/−) mice in the same background were exposed to either normoxia (N) or HO for 72 h. At the end of the experiment mice were anesthetized, BAL fluid was collected, lungs were perfused with fresh PBS several times, and whole lungs without trachea were paraffin-embedded. A–C, paraffin-embedded lung tissues from normoxia or HO animals were, sectioned, and immunostained with anti-phospho-MLC (A), anti-phospho-Src (B), or anti-phospho-cortactin (C) antibodies and examined under immunofluorescence microscopy using 60× oil objective. D, lung tissues from normoxia or HO-exposed animals were stored in formalin for 24 h before processing for staining with hematoxylin and eosin and lung morphology was evaluated using 40 X objective. E, BAL fluid collected from normoxia- or HO-exposed animals were subjected to cytospin, and differential cell counts were performed. Shown is a graphic representation of macrophages (M) and neutrophils (N) in BAL fluid from wild type and nmMLCK−/− mice exposed to normoxia or hyperoxia. Values are the mean ± S.D. from three independent experiments. *, significantly different from animals exposed to normoxia (p < 0.05); **, significantly different from animals exposed to normoxia (p < 0.01); ***, significantly different from wild type mice exposed to hyperoxia (p < 0.005). F and G, BAL fluid from mice exposed to normoxia or hyperoxia was analyzed for H2O2 (F) and total protein (G). Values are the mean ± S.D. from three independent experiments. *, significantly different from animals exposed to normoxia (p < 0.05); **, significantly different from wild type animals exposed to hyperoxia (p < 0.01).

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: In Vivo, Knock-Out, Immunofluorescence, Microscopy, Staining

    Overexpression of FLAG-tagged nmMLCK wild type in nmMLCK-deficient mouse lung ECs restores hyperoxia-induced ROS/O2˙̄ production. Mouse lung endothelial cells isolated from 4-5-week-old C57BL/6 and nmMLCK−/− null mice were isolated using collagenase A as described under “Experimental Procedures.” In A and B, lungs ECs grown to ∼80% confluence from wild type and nmMLCK−/− mice were exposed to normoxia or hyperoxia for 3 h, and total ROS and superoxide generated in cells were quantified as described under “Experimental Procedures.” Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different from normoxia (p < 0.01); **, significantly different from untreated hyperoxia (p < 0.05). In C and D, lung ECs from nmMLCK−/− null mice were infected with vector control or adenoviral human nmMLCK (AdMLCK (WT)) (5 pfu/cell) in EBM-2 complete medium for 24 h before exposure to normoxia or hyperoxia for 3 h. Total ROS and superoxide accumulation in cells were measured by DCFDA and hydroethidine (HE) fluorescence. Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different adenoviral nmMLCK wild type-infected cells exposed to normoxia (p < 0.01). In E, cell lysates (20 μg proteins) from wild type, nmMLCK−/−, and FLAG-tagged human nmMLCK-infected mouse lung ECs were subjected to SDS-PAGE and immunoblotted with anti-MLCK, anti-FLAG, and anti-actin antibodies. A representative immunoblot (IB) from three independent experiments is shown. Immunoblots were analyzed by densitometry and quantified.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Overexpression of FLAG-tagged nmMLCK wild type in nmMLCK-deficient mouse lung ECs restores hyperoxia-induced ROS/O2˙̄ production. Mouse lung endothelial cells isolated from 4-5-week-old C57BL/6 and nmMLCK−/− null mice were isolated using collagenase A as described under “Experimental Procedures.” In A and B, lungs ECs grown to ∼80% confluence from wild type and nmMLCK−/− mice were exposed to normoxia or hyperoxia for 3 h, and total ROS and superoxide generated in cells were quantified as described under “Experimental Procedures.” Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different from normoxia (p < 0.01); **, significantly different from untreated hyperoxia (p < 0.05). In C and D, lung ECs from nmMLCK−/− null mice were infected with vector control or adenoviral human nmMLCK (AdMLCK (WT)) (5 pfu/cell) in EBM-2 complete medium for 24 h before exposure to normoxia or hyperoxia for 3 h. Total ROS and superoxide accumulation in cells were measured by DCFDA and hydroethidine (HE) fluorescence. Values for ROS and superoxide production are the mean ± S.D. from three independent experiments done in triplicate. *, significantly different adenoviral nmMLCK wild type-infected cells exposed to normoxia (p < 0.01). In E, cell lysates (20 μg proteins) from wild type, nmMLCK−/−, and FLAG-tagged human nmMLCK-infected mouse lung ECs were subjected to SDS-PAGE and immunoblotted with anti-MLCK, anti-FLAG, and anti-actin antibodies. A representative immunoblot (IB) from three independent experiments is shown. Immunoblots were analyzed by densitometry and quantified.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Over Expression, Isolation, Generated, Infection, Plasmid Preparation, Fluorescence, SDS Page, Western Blot

    Overexpression of FLAG-tagged nmMLCK wild type in nmMLCK-deficient mouse lung ECs restores hyperoxia-induced redistribution of p-MLC, p-Src, and p-cortactin to cell periphery. Mouse lung ECs isolated from 4–5-week-old C57BL/6 wild type and nmMLCK−/− mice were grown on 8-well slide chambers to ∼80% confluence. In some experiments ECs isolated from nmMLCK−/− null mice were infected with vector control or adenoviral human nmMLCK wild type (AdMLCK, 5 pfu/cell) for 24 h. Cells were exposed to normoxia (N) or HO for 3 h, washed, fixed, permeabilized, and probed with anti-phospho-MLC (A), anti-phospho-Src (B), or anti-phospho-cortactin (C) antibodies and examined by immunofluorescence microscopy using a 60× oil objective. A representative image from three independent experiments is shown.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Overexpression of FLAG-tagged nmMLCK wild type in nmMLCK-deficient mouse lung ECs restores hyperoxia-induced redistribution of p-MLC, p-Src, and p-cortactin to cell periphery. Mouse lung ECs isolated from 4–5-week-old C57BL/6 wild type and nmMLCK−/− mice were grown on 8-well slide chambers to ∼80% confluence. In some experiments ECs isolated from nmMLCK−/− null mice were infected with vector control or adenoviral human nmMLCK wild type (AdMLCK, 5 pfu/cell) for 24 h. Cells were exposed to normoxia (N) or HO for 3 h, washed, fixed, permeabilized, and probed with anti-phospho-MLC (A), anti-phospho-Src (B), or anti-phospho-cortactin (C) antibodies and examined by immunofluorescence microscopy using a 60× oil objective. A representative image from three independent experiments is shown.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Over Expression, Isolation, Infection, Plasmid Preparation, Immunofluorescence, Microscopy

    Proposed model on involvement of ∼214-kDa nmMLCK in assembly and activation of non-phagocytic NADPH oxidase and ROS/superoxide production in lung endothelium. As depicted in the model, both cortactin and p47phox are diffused throughout the cell and mostly co-localized to the same intracellular compartment. Upon exposure to hyperoxia, nmMLCK facilitates the assembly and association of cortactin, p47phox, Src, and other components to the caveolin-enriched microdomains at the cell periphery for enhanced ROS/superoxide production.

    Journal: The Journal of Biological Chemistry

    Article Title: Novel Role for Non-muscle Myosin Light Chain Kinase (MLCK) in Hyperoxia-induced Recruitment of Cytoskeletal Proteins, NADPH Oxidase Activation, and Reactive Oxygen Species Generation in Lung Endothelium *

    doi: 10.1074/jbc.M111.294546

    Figure Lengend Snippet: Proposed model on involvement of ∼214-kDa nmMLCK in assembly and activation of non-phagocytic NADPH oxidase and ROS/superoxide production in lung endothelium. As depicted in the model, both cortactin and p47phox are diffused throughout the cell and mostly co-localized to the same intracellular compartment. Upon exposure to hyperoxia, nmMLCK facilitates the assembly and association of cortactin, p47phox, Src, and other components to the caveolin-enriched microdomains at the cell periphery for enhanced ROS/superoxide production.

    Article Snippet: Antibodies for MLCK, MLC, cortactin, and p47, protein A/G plus agarose, and BSA were from Santa Cruz Biotechnology (Santa Cruz, CA); scrambled RNA and siRNA MLCK were from Dharmacon (Lafayette, CO); shMLCK-GFP was from Open Biosystems (Huntsville, AL); adenoviral construct nmMLCK-FLAG (WT) was generated at the services of the University of Iowa Gene Transfer Vector Core (Iowa City, IA); Rac1 antibody was from BD Biosciences; Gene silencer was from Genlantis (San Diego, CA); FuGENE HD transfection reagent was from Roche Applied Science; phosphatase inhibitor mixture, ML-7, and antibodies for actin, phospho-Src (Tyr-418), and FLAG were from Sigma; anti-phospho-cortactin (Tyr-486) antibody was from Chemicon (Boronia, Australia); microscopy Lab-Tek slide chambers were from Electron Microscopy Sciences (Hatfield, PA); glass bottom 35-mm dishes were from MatTek Corp. (Ashland, MA); incubator chamber for hyperoxia exposure was from Billups-Rothenberg (Del Mar, CA); cell lysis buffer and antibodies for p-MLC and caveolin-1 were from Cell Signaling Technology (Danvers, MA).

    Techniques: Activation Assay